Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
905.38
-3.66 (-0.40%)
Official Closing Price
Updated: 7:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
85
86
Next >
Eli Lilly's Commercial Moat, Competitor Landscape: BofA Emphasizes Strength in Incretin Space, Undervalued Assets
March 01, 2024
Eli Lilly: BofA Securities rates it a top pick in Biopharma, with a YTD performance of +29%. Analysts highlight undervalued opportunities in heart disease, sleep apnea, and liver disease. Price target...
Via
Benzinga
A Closer Look at 18 Analyst Recommendations For Eli Lilly and Co
March 01, 2024
Via
Benzinga
Stock Market Rally At Highs After Big Earnings, Inflation Data: Weekly Review
March 01, 2024
The Nasdaq is on the cusp of setting a record high.
Via
Investor's Business Daily
Topics
Economy
Exposures
Interest Rates
Eli Lilly Stock And The Road To 1,000: Weight-Loss Drugs Could Generate $81 Billion
March 01, 2024
Wall Street isn't properly taking into account Lilly's next-generation drugs, an analyst says.
Via
Investor's Business Daily
$1000 Invested In This Stock 10 Years Ago Would Be Worth $13,000 Today
March 01, 2024
Via
Benzinga
3 Healthcare Stocks That Have Outperformed Nvidia Since 2022
March 01, 2024
The healthcare sector is no slouch when it comes to top-performing growth stocks.
Via
The Motley Fool
Got $200? 2 Dividend Stocks to Buy and Hold Forever
March 01, 2024
Trust these two real estate stocks to be attractively priced and proven performers.
Via
The Motley Fool
2 Stocks That Could Turn $1,000 Into $2,500 in 5 Years
March 01, 2024
It will take a lot, but this goal isn't out of reach for these stocks.
Via
The Motley Fool
The Hot List: 3 AI Stocks Worth Buying on Weakness
March 01, 2024
Firms using AI directly can be great picks for long-term investors, such as these three AI stocks to buy on weakness.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
These 4 Stocks Are the "Magnificent Seven" of Healthcare
March 01, 2024
Their growth trajectories aren't as meteoric, but they're still notable.
Via
The Motley Fool
Ozempic, Wegovy Other Weight-Loss Drugs Won't Solve Global Obesity Crisis Affecting 1B People, WHO Warns
March 01, 2024
The World Health Organization has cautioned that the increasing global obesity crisis, which now affects over a billion people, cannot be resolved by the use of obesity medications alone.
Via
Benzinga
The Best And Worst Performing Stocks Of February 2024
February 29, 2024
The average S&P 500 stock rose 3.87% in February even though the index itself was up more than 5%.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Top Stocks Not Named Nvidia You Need To Know About In 2024: Here's What Investors Think About Them (Wall Street Vs. Reddit)
February 29, 2024
Nvidia Corp. is one of the leading top stocks with 60% gain in 2024, but other lesser-known names have outperformed.
Via
Benzinga
5 Investors Betting Big on Weight Watchers (WW) Stock as Oprah Backs Out
February 29, 2024
WW stock is falling lower after its earnings, adding that Oprah Winfrey would step down from the board of directors.
Via
InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
February 29, 2024
Via
Benzinga
Could These 3 Companies Headline a "Magnificent Seven" of Biotech Stocks?
February 29, 2024
These stocks meet many of the criteria long-term investors look for.
Via
The Motley Fool
Viking Therapeutics: A Teachable Moment About Investing for the Long Term
February 29, 2024
The biotherapeutics company's weight loss candidate scored a major win this week.
Via
The Motley Fool
Viking Therapeutics Just Soared 120% on Optimism About Its Weight Loss Candidate. Too Late to Buy?
February 29, 2024
Viking stock surged in the triple digits in one trading session.
Via
The Motley Fool
Is Viking Therapeutics a Buy Now?
February 29, 2024
The stock recently jumped more than 100% overnight thanks to surprising results from its anti-obesity candidate.
Via
The Motley Fool
Stock Splits Watch: 3 Likely Candidates to Keep on Your Radar in 2024
February 28, 2024
Investors should keep a close eye on these companies as rumors grow louder that stock splits are imminent.
Via
InvestorPlace
Opportunities For Investors Beyond AI And Nvidia – Biotech Breaks Out, New GDP Data Shows Inflation Pressure
February 28, 2024
To gain an edge, this is what you need to know today.
Via
Benzinga
Topics
Artificial Intelligence
Economy
Exposures
Artificial Intelligence
Interest Rates
Viking Therapeutics' Weight Loss Study Data Outperformed Novo Nordisk, Eli Lilly Studies, Analysts Say
February 28, 2024
Viking Therapeutics achieves significant weight loss in the VENTURE trial, outperforming rivals in body weight reductions.
Via
Benzinga
Large US Drug Makers Highlight Indian Market For Their Blockbuster Drugs Including For Weight Loss
February 28, 2024
Eli Lilly's CEO, David Ricks, outlines plans to launch the obesity drug Tirzepatide in India next year, presenting opportunities amid competition from Novo Nordisk. Bristol Myers Squibb expands its R&D...
Via
Benzinga
Jim Cramer Weighs In On Palo Alto, Eli Lilly And Salesforce, Says Price Target Bump For This Stock A 'Red Flag'
February 28, 2024
During Tuesday's CNBC Investing Club Morning Meeting, U.S. stocks exhibited mixed performance, prompting a closer look at prevailing market themes. Cybersecurity emerged as a key focus, with Jim Cramer...
Via
Benzinga
Why Novo Nordisk and Eli Lilly Stocks Slipped Today
February 27, 2024
A competitor to Wegovy and Zepbound might appear on pharmacy shelves before long.
Via
The Motley Fool
Are Nvidia, Eli Lilly, AMD's High Equity Valuations In Peril From Higher Rates?
February 27, 2024
The Fed's aggressive rate cycle in 2022 and 2023 did not fundamentally spook equities anywhere near as much as what happened in the 1970s.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Beam Rockets 27%, Hitting A Year High, On Its Efforts To Take On Crispr's New Gene-Editing Drug
February 27, 2024
Both companies are working on treatments for genetic disorders.
Via
Investor's Business Daily
Stock Spotlight: 3 Picks ChatGPT Urges You Not to Miss
February 27, 2024
Everybody seems to want ChatGPT stock picks now that generative AI is popular with investors. Here are three recommended by the app.
Via
InvestorPlace
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect
February 27, 2024
Hedge funds are shifting towards stability and value by favoring the health care sector over booming tech stocks.
Via
Benzinga
Viking Therapeutics Skyrockets On Weight-Loss Drug Trial Results
February 27, 2024
Eli Lilly and Novo Nordisk fell modestly.
Via
Investor's Business Daily
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
85
86
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.